These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19903497)

  • 21. Cytokine genetic adjuvant facilitates prophylactic intravascular DNA vaccine against acute and latent herpes simplex virus infection in mice.
    Cui FD; Asada H; Jin ML; Kishida T; Shin-Ya M; Nakaya T; Kita M; Ishii M; Iwai M; Okanoue T; Imanishi J; Mazda O
    Gene Ther; 2005 Jan; 12(2):160-8. PubMed ID: 15470476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
    Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge.
    Sin JI; Kim JJ; Arnold RL; Shroff KE; McCallus D; Pachuk C; McElhiney SP; Wolf MW; Pompa-de Bruin SJ; Higgins TJ; Ciccarelli RB; Weiner DB
    J Immunol; 1999 Mar; 162(5):2912-21. PubMed ID: 10072541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel adjuvant, the general opioid antagonist naloxone, elicits a robust cellular immune response for a DNA vaccine.
    Jamali A; Mahdavi M; Hassan ZM; Sabahi F; Farsani MJ; Bamdad T; Soleimanjahi H; Motazakker M; Shahabi S
    Int Immunol; 2009 Mar; 21(3):217-25. PubMed ID: 19174474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic immunisation against hepatitis B using whole bacteriophage lambda particles.
    March JB; Clark JR; Jepson CD
    Vaccine; 2004 Apr; 22(13-14):1666-71. PubMed ID: 15068849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88.
    Tengvall S; O'Hagan D; Harandi AM
    Antiviral Res; 2008 Jun; 78(3):202-14. PubMed ID: 18276020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasmid DNA vaccines are effective in the absence of IFNgamma.
    Hassett DE; Zhang J; Whitton JL
    Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
    Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ
    J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of LIGHT adjuvant on kinetics of T-cell responses induced by HSV-1 DNA immunization.
    Gorgian Mohammady M; Bamdad T; Parsania M; Soleimanjahi H; Pouyanfard S; Hashemi H; Asghari-Jafarabadi M
    Iran J Immunol; 2011 Jun; 8(2):76-84. PubMed ID: 21705834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple alternating immunizations with DNA vaccine and replication incompetent adenovirus expressing gB of pseudorabies virus protect animals against lethal virus challenge.
    Kim SJ; Kim HK; Han YW; Aleyas AG; George JA; Yoon HA; Yoo DJ; Kim K; Eo SK
    J Microbiol Biotechnol; 2008 Jul; 18(7):1326-34. PubMed ID: 18667863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Large-scale comparison of experimental adjuvants with herpes simplex virus vaccine reveals a correlation of protection with IgG2a and IgG2b responses.
    Simms JR; Jennings R; Richardson VJ; Heath AW
    J Med Virol; 2002 Sep; 68(1):82-91. PubMed ID: 12210434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A DNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protects mice against lethal challenge.
    De Paula SO; Lima DM; de Oliveira França RF; Gomes-Ruiz AC; da Fonseca BA
    Arch Virol; 2008; 153(12):2215-23. PubMed ID: 19002647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA priming and killed virus boosting vaccination strategy can augment the immune response to pseudorabies virus.
    Chen ZH; Guo X; Ge XN; Jia H; Yang HC
    Acta Virol; 2007; 51(3):163-70. PubMed ID: 18076306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipopeptide epitopes extended by an Nepsilon-palmitoyl-lysine moiety increase uptake and maturation of dendritic cells through a Toll-like receptor-2 pathway and trigger a Th1-dependent protective immunity.
    Zhu X; Ramos TV; Gras-Masse H; Kaplan BE; BenMohamed L
    Eur J Immunol; 2004 Nov; 34(11):3102-14. PubMed ID: 15368273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage.
    Meola A; Delmastro P; Monaci P; Luzzago A; Nicosia A; Felici F; Cortese R; Galfrè G
    J Immunol; 1995 Apr; 154(7):3162-72. PubMed ID: 7534789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of timing strategy of LIGHT, a new TNF superfamily on immune platform induced by HSV-1 gB DNA vaccine.
    Pouyanfard S; Bamdad T; Parsania M; Hashemi H; Mohammadi MG
    Cytokine; 2010 Apr; 50(1):99-103. PubMed ID: 20097089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of recombinant herpes simplex virus 1 glycoprotein D candidate vaccines in mice.
    Durmanová V; Mosko T; Sapák M; Kosovský J; Rezuchová I; Buc M; Rajcáni J
    Acta Microbiol Immunol Hung; 2006 Dec; 53(4):459-77. PubMed ID: 17278713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological properties of a DNA plasmid encoding a chimeric protein of herpes simplex virus type 2 glycoprotein B and glycoprotein D.
    Domingo C; Gadea I; Pardeiro M; Castilla C; Fernández S; Fernández-Clua MA; De la Cruz Troca JJ; Punzón C; Soriano F; Fresno M; Tabarés E
    Vaccine; 2003 Sep; 21(25-26):3565-74. PubMed ID: 12922084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody-inducing properties of a prototype bivalent herpes simplex virus/enterotoxigenic Escherichia coli DNA vaccine.
    Lásaro MO; Alves AM; Botosso VF; Durigon EL; Ferreira LC
    FEMS Immunol Med Microbiol; 2003 Jan; 35(1):25-31. PubMed ID: 12589954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA vaccine delivery by densely-packed and short microprojection arrays to skin protects against vaginal HSV-2 challenge.
    Kask AS; Chen X; Marshak JO; Dong L; Saracino M; Chen D; Jarrahian C; Kendall MA; Koelle DM
    Vaccine; 2010 Nov; 28(47):7483-91. PubMed ID: 20851091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.